In contrast, in triple-negative breast cancer (TNBC), upregulated circEGFR binding to ANXA2 promotes ANXA2 translocation to the plasma membrane, leading to the release of TFEB from the ANXA2-TFEB complex and causing TFEB nuclear translocation [72]. The gene discussed is ANXA2; the disease is triple-negative breast carcinoma.